Table 1.
Demographic data and MRI results at diagnosis
| All patients | Females | Males | |
|---|---|---|---|
| N = 40 | N = 31 (77.5%) | N = 9 (22.5%) | |
| Age (years) | 26.5 (14–63) | 25 (14–41) | 31 (18–63) |
| MRI at diagnosis | N = 39a | N = 30 (76.9%)a | N = 9 (23.1%) |
| Tumor size | |||
| No adenoma visible | 2 (5.1%) | 2 (6.7%) | 0 (0.0%) |
| Microadenoma | 24 (61.5%) | 19 (63.3%) | 5 (55.6%) |
| Macroadenoma | 13 (33.3%) | 9 (30.0%) | 4 (44.4%) |
| Giant adenoma | 0 (0.0%) | 0 (0.0%) | 0 (0.0%) |
| CSI (> KNOSP 2) | |||
| Certain | 2 (5.1%) | 0 (0.0%) | 2 (22.2%) |
| Unknown | 3 (7.7%) | 3 (10.0%) | 0 (0.0%) |
| Optic chiasma compression | |||
| Certain | 1 (2.6%) | 0 (0.0%) | 1 (11.1%) |
| Possible | 1 (2.6%) | 0 (0.0%) | 1 (11.1%) |
| Apoplexy | |||
| Certain | 2 (5.1%) | 2 (6.7%) | 0 (0.0%) |
| Possible | 1 (2.6%) | 1 (3.3%) | 0 (0.0%) |
Demographical data and MRI results at diagnosis for all patients and for females and males separately. Values are presented as median (range) or number (percentage)
CSI cavernous sinus invasion, DA dopamine agonist
aThe MRI scan at diagnosis was unavailable in one patient who was diagnosed abroad